Confo Therapeutics

Technologiepark 30
9052 Gent Zwijnaarde
BE
Confo Therapeutics
Foundation date
11/06/2015
Sector
#Biotechnology - TherapeuticsSubsector
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets.
This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.
Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
0712 '23
The GxP Academy: Cleaning Validatie
Event by: Advipro
Latest news
More news-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
1 day ago
Read more
-
Celyad announces management change
Friday December 1st 2023
Read more
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
Jobs by Confo Therapeutics
More jobs-
-
08/11/23
East Flanders
(jr) Research Associate Molecular Engineering/Antibody Production
Permanent
Confo Therapeutics
More info?
Ellen Telleir
Communication Coordinator